Chronic Phase Chronic Myelogenous Leukemia Recruiting Phase 2 Trials for Thiotepa (DB04572)

IndicationStatusPhase
DBCOND0028870 (Chronic Phase Chronic Myelogenous Leukemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01760655Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesTreatment